iBio, Inc. IBIO recently approved a 20-to-1 reverse stock split of its common stock, which will take effect on November 29, 2023. This means that every 20 shares of existing stock will be combined into one share, but the total value remains the same.
Fractional shareholders will receive cash payments, and the total outstanding shares will decrease significantly. Stock options, warrants and equity plans will be adjusted accordingly.
The company's transfer agent will provide instructions for exchanging old stock certificates for new ones, while shareholders with shares in brokerage accounts don't need to take action.
See Also: Why ChargePoint Stock Hit A New All-Time Low Today
According to data from Benzinga Pro, iBio has a 52-week high of $2.60 and a 52-week low of $0.20.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
